232 related articles for article (PubMed ID: 26346867)
1. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
[TBL] [Abstract][Full Text] [Related]
2. Response to Fontana et al.
Collyer E; Kay M
Am J Gastroenterol; 2016 Feb; 111(2):297. PubMed ID: 26882951
[No Abstract] [Full Text] [Related]
3. Response to Collyer et al.
Fontana RJ
Am J Gastroenterol; 2016 Feb; 111(2):297-8. PubMed ID: 26882950
[No Abstract] [Full Text] [Related]
4. Amoxicillin-Clavulanate-Induced Liver Injury.
deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
[TBL] [Abstract][Full Text] [Related]
5. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
6. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
Kwo PY; Cohen SM; Lim JK
Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
[TBL] [Abstract][Full Text] [Related]
7. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
[No Abstract] [Full Text] [Related]
8. Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring.
Shamseddeen H; Vilar-Gomez E; Chalasani N; Myers RP; Subramanian GM; Shlevin HH; Allgood AE; Orman ES
Drug Saf; 2020 Mar; 43(3):281-290. PubMed ID: 31907854
[TBL] [Abstract][Full Text] [Related]
9. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
10. Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats.
Kagawa T; Shirai Y; Oda S; Yokoi T
Toxicol Sci; 2018 Nov; 166(1):228-239. PubMed ID: 30125006
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Xu HM; Chen Y; Xu J; Zhou Q
World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes.
Quintás G; Martínez-Sena T; Conde I; Pareja Ibars E; Kleinjans J; Castell JV
Arch Toxicol; 2021 Sep; 95(9):3049-3062. PubMed ID: 34274980
[TBL] [Abstract][Full Text] [Related]
14. Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
Alhaddad O; Elsabaawy M; Abdelsameea E; Abdallah A; Shabaan A; Ehsan N; Elrefaey A; Elsabaawy D; Salama M
Sci Rep; 2020 Mar; 10(1):5124. PubMed ID: 32198411
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.
Asgarshirazi M; Shariat M; Sheikh M
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):296-302. PubMed ID: 28603098
[TBL] [Abstract][Full Text] [Related]
17. Large dose means significant effect--dose and effect relationship of Chi-Dan-Tui-Huang decoction on alpha-naphthylisothiocyanate-induced cholestatic hepatitis in rats.
Zhao Y; Ma X; Wang J; Wen R; Jia L; Zhu Y; Li R; Wang R; Li J; Wang L; Li Y; Xiao X
BMC Complement Altern Med; 2015 Apr; 15():104. PubMed ID: 25889085
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histologic features of Azathioprine-induced hepatotoxicity.
Siramolpiwat S; Sakonlaya D
Scand J Gastroenterol; 2017 Aug; 52(8):876-880. PubMed ID: 28388864
[TBL] [Abstract][Full Text] [Related]
19. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.
Medina-Caliz I; Robles-Diaz M; Garcia-Muñoz B; Stephens C; Ortega-Alonso A; Garcia-Cortes M; González-Jimenez A; Sanabria-Cabrera JA; Moreno I; Fernandez MC; Romero-Gomez M; Navarro JM; Barriocanal AM; Montane E; Hallal H; Blanco S; Soriano G; Roman EM; Gómez-Dominguez E; Castiella A; Zapata EM; Jimenez-Perez M; Moreno JM; Aldea-Perona A; Hernández-Guerra M; Prieto M; Zoubek ME; Kaplowitz N; Lucena MI; Andrade RJ;
J Hepatol; 2016 Sep; 65(3):532-42. PubMed ID: 27184533
[TBL] [Abstract][Full Text] [Related]
20. The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease.
Iluz-Freundlich D; Zhang M; Uhanova J; Minuk GY
Ann Hepatol; 2020; 19(2):204-208. PubMed ID: 31628070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
